SARCOMATOID CARCINOMA OF THE LUNG

SARCOMATOID CARCINOMA OF THE LUNG was reported 21 times

SARCOMATOID CARCINOMA OF THE LUNG is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Sigma-1 Agonist [EPC] 3 0.0003
1 Non-narcotic Antitussive [EPC] 3 0.0002
2 Stimulant Laxative [EPC] 2 0.0001
3 Antimycobacterial [EPC] 1 0.0000
4 Penem Antibacterial [EPC] 1 0.0000
5 Estrogen Receptor Antagonist [EPC] 1 0.0000
6 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
7 Microtubule Inhibitor [EPC] 3 0.0000
8 Aromatase Inhibitor [EPC] 2 0.0000
9 Glycopeptide Antibacterial [EPC] 1 0.0000
10 Histamine-2 Receptor Antagonist [EPC] 2 0.0000
11 Platinum-based Drug [EPC] 4 0.0000
12 Expectorant [EPC] 3 0.0000
13 Cardiac Glycoside [EPC] 1 0.0000
14 Topoisomerase Inhibitor [EPC] 1 0.0000
15 Alkylating Drug [EPC] 3 0.0000
16 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
17 Osmotic Laxative [EPC] 3 0.0000
18 5-alpha Reductase Inhibitor [EPC] 1 0.0000
19 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
20 Factor Xa Inhibitor [EPC] 2 0.0000
21 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
22 Loop Diuretic [EPC] 3 0.0000
23 Azole Antifungal [EPC] 1 0.0000
24 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
25 Kinase Inhibitor [EPC] 3 0.0000
26 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
27 Opioid Agonist [EPC] 1 0.0000
28 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
29 Platelet Aggregation Inhibitor [EPC] 2 0.0000
30 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
31 Corticosteroid [EPC] 4 0.0000
32 Benzodiazepine [EPC] 2 0.0000
33 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000